ZA965800B - Novel quinoxaline- and quinoxalinylalkane-phosphonic acids - Google Patents
Novel quinoxaline- and quinoxalinylalkane-phosphonic acidsInfo
- Publication number
- ZA965800B ZA965800B ZA965800A ZA965800A ZA965800B ZA 965800 B ZA965800 B ZA 965800B ZA 965800 A ZA965800 A ZA 965800A ZA 965800 A ZA965800 A ZA 965800A ZA 965800 B ZA965800 B ZA 965800B
- Authority
- ZA
- South Africa
- Prior art keywords
- quinoxalinylalkane
- phosphonic acids
- novel quinoxaline
- quinoxaline
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH200995 | 1995-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA965800B true ZA965800B (en) | 1997-01-10 |
Family
ID=4223780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA965800A ZA965800B (en) | 1995-07-10 | 1996-07-09 | Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0837864A1 (fr) |
JP (1) | JPH11508902A (fr) |
KR (1) | KR19990028839A (fr) |
AU (1) | AU6516296A (fr) |
BR (1) | BR9609644A (fr) |
CA (1) | CA2224718A1 (fr) |
CZ (1) | CZ5398A3 (fr) |
HU (1) | HUP9901345A3 (fr) |
IL (1) | IL122872A0 (fr) |
NO (1) | NO980095L (fr) |
PL (1) | PL324340A1 (fr) |
SK (1) | SK2798A3 (fr) |
TR (1) | TR199800022T1 (fr) |
WO (1) | WO1997003079A1 (fr) |
ZA (1) | ZA965800B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2264171T3 (es) * | 1996-10-24 | 2006-12-16 | Novartis Ag | Acidos aminoalcanofosfonicos sustituidos. |
US6841684B2 (en) | 1997-12-04 | 2005-01-11 | Allergan, Inc. | Imidiazoles having reduced side effects |
US6329369B1 (en) | 1997-12-04 | 2001-12-11 | Allergan Sales, Inc. | Methods of treating pain and other conditions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5118675A (en) * | 1991-02-15 | 1992-06-02 | American Home Products Corporation | Quinoxaline phosphono-amino acids |
IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1996
- 1996-07-01 PL PL96324340A patent/PL324340A1/xx unknown
- 1996-07-01 BR BR9609644A patent/BR9609644A/pt not_active Application Discontinuation
- 1996-07-01 CZ CZ9853A patent/CZ5398A3/cs unknown
- 1996-07-01 CA CA002224718A patent/CA2224718A1/fr not_active Abandoned
- 1996-07-01 TR TR1998/00022T patent/TR199800022T1/xx unknown
- 1996-07-01 WO PCT/EP1996/002866 patent/WO1997003079A1/fr not_active Application Discontinuation
- 1996-07-01 SK SK27-98A patent/SK2798A3/sk unknown
- 1996-07-01 IL IL12287296A patent/IL122872A0/xx unknown
- 1996-07-01 AU AU65162/96A patent/AU6516296A/en not_active Abandoned
- 1996-07-01 JP JP9505465A patent/JPH11508902A/ja active Pending
- 1996-07-01 KR KR1019980700140A patent/KR19990028839A/ko not_active Application Discontinuation
- 1996-07-01 HU HU9901345A patent/HUP9901345A3/hu unknown
- 1996-07-01 EP EP96924829A patent/EP0837864A1/fr not_active Withdrawn
- 1996-07-09 ZA ZA965800A patent/ZA965800B/xx unknown
-
1998
- 1998-01-09 NO NO980095A patent/NO980095L/no unknown
Also Published As
Publication number | Publication date |
---|---|
SK2798A3 (en) | 1998-07-08 |
NO980095D0 (no) | 1998-01-09 |
IL122872A0 (en) | 1998-08-16 |
JPH11508902A (ja) | 1999-08-03 |
TR199800022T1 (xx) | 1998-05-21 |
CA2224718A1 (fr) | 1997-01-30 |
MX9800332A (es) | 1998-07-31 |
KR19990028839A (ko) | 1999-04-15 |
NO980095L (no) | 1998-03-05 |
AU6516296A (en) | 1997-02-10 |
HUP9901345A2 (hu) | 1999-08-30 |
PL324340A1 (en) | 1998-05-25 |
CZ5398A3 (cs) | 1998-06-17 |
WO1997003079A1 (fr) | 1997-01-30 |
BR9609644A (pt) | 1999-05-11 |
HUP9901345A3 (en) | 2000-01-28 |
EP0837864A1 (fr) | 1998-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6490396A (en) | Substituted-pent-4-ynoic acids | |
HK1002864A1 (en) | Water-dissoluble narobomycin ester | |
PL327445A1 (en) | Novel process | |
GB9325558D0 (en) | Percaboxylic acids | |
EP0801644A4 (fr) | Acides polyarylcarbamoylazadioques et carbamoylalcanedio ques | |
NZ286622A (en) | Fluorophenylalkenylcarboxylic acid guanidides | |
DE69616581D1 (en) | Polyurethanhartschäume | |
ZA952008B (en) | 5-vinyl- and 5-ethinyl-quinolene- and -naphthyridone- carboxylic acids | |
DE69610843D1 (en) | Hydroformylierungsverfahren | |
PL332553A1 (en) | 3-alkooxyisooxazol-4-yl-substituted 2-aminocarboxylic acids | |
ZA968451B (en) | Novel sulfonylaminopyrimidines | |
SI1043332T1 (sl) | Dipeptidi, ki obsegajo ciklopentan-beta-aminokisline | |
EP0745413A3 (fr) | Filtre de liquide | |
DE59602888D1 (en) | Breitstreckaggregat | |
GB9510126D0 (en) | Novel process | |
HUP9901345A3 (en) | Novel quinoxaline- and quinoxalinylalkane-phosphonic acids | |
ZA967421B (en) | Novel process | |
GB9500977D0 (en) | Novel process | |
GB9505504D0 (en) | Sprayhood | |
DE59604506D1 (en) | Rückkühlsystem | |
GB2304713B (en) | Novel process | |
GB2300646B (en) | Firelighting | |
GB9504078D0 (en) | Novel process | |
GB9614562D0 (en) | Novel process | |
GB9504060D0 (en) | Novel process |